Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1697658 Target Snapshot

Pleiotropic ABC efflux transporter of multiple drugs · SINGLE PROTEIN · Saccharomyces cerevisiae S288c

23Compounds
2Assays
13Approved Drugs
23.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P33302. Use UniProt P33302 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P33302 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Pleiotropic ABC efflux transporter of multiple drugs as ChEMBL target CHEMBL1697658, mapped to UniProt P33302. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Pleiotropic ABC efflux transporter of multiple drugs
SINGLE PROTEIN · Saccharomyces cerevisiae S288c
As of 2026-09-13
ChEMBL target ID
CHEMBL1697658
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P33302
Pleiotropic ABC efflux transporter of multiple drugs
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Pleiotropic ABC efflux transporter of multiple drugs is the right protein anchor across sources, using UniProt P33302 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPleiotropic ABC efflux transporter of multiple drugs
UniProt AccessionP33302
Component TypeProtein
Sequence Length1511 aa

Pleiotropic ABC efflux transporter of multiple drugs

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Pleiotropic ABC efflux transporter of multiple drugs, mapped to UniProt P33302. Sequence length is 1511 aa.

Mapped IDP33302
Review namePleiotropic ABC efflux transporter of multiple drugs
OrganismSaccharomyces cerevisiae S288c
Clinical Profile

Clinical Phase Distribution

13
Approved
1
Phase II
Assay Mix

Activity Type Distribution

IC5023.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1688548 6.16 IC50 700.0 Preclinical
CHEMBL1688549 5.89 IC50 1300.0 Preclinical
CHEMBL479 5.89 IC50 1300.0 Approved
CHEMBL422 5.85 IC50 1400.0 Approved
CHEMBL567 5.85 IC50 1400.0 Approved
CHEMBL726 5.77 IC50 1700.0 Approved
CHEMBL728 5.77 IC50 1700.0 Approved
CHEMBL1378 5.64 IC50 2300.0 Approved
CHEMBL1688550 5.51 IC50 3100.0 Preclinical
CHEMBL824 5.5 IC50 3200.0 Preclinical
Distribution

pChEMBL Value Distribution

7
5.0
9
5.5
1
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

2
Total Assays
21
Tested Compounds
1
Assay Types
Binding — 2 assays, 21 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 21 5.4
single protein format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine